Fundraising FoxOdyssey Group International
OTC: ODYYIrvine, US · Nevada corporation
Find your way into Odyssey Group International
Sign up to see every warm intro you have to Odyssey Group International
- Paths you didn't know you had: your email and LinkedIn already hold routes to the Odyssey Group International team. We find them for you
- 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
- Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone
Days of research, done the moment you sign in, with every route ranked by how warm it is.
Odyssey Health develops medical technologies aimed at addressing unmet clinical needs with significant market potential.
Founders & leadership
JG
John GandolfoNamed on SEC filing
CF
Christine FarrellNamed on SEC filing
JV
Jacob VanlandinghamNamed on SEC filing
JC
Jerome CaseyNamed on SEC filing
JM
Joseph Michael RedmondNamed on SEC filing
JC
Jeffrey ConroyNamed on SEC filing
Reported raises · per SEC filings
Form D private placements$2.6M disclosed across 2 of 3 rounds · 2020–2022
▶$1.4MraisedJun 2022 · 26 investors · Other Health CareRule 506(b)
▶$1.4MraisedJun 2022 · 26 investors · Other Health Care
Rule 506(b)Officers, directors & promoters on the filing
- John GandolfoDirector
- Christine FarrellExecutive Officer
- Joseph Michael RedmondExecutive Officer, Director
- Ricky RichardsonDirector
- Jerome CaseyDirector
- Jeffrey ConroyDirector
- Offering amount
- $5M
- Amount sold
- $1.4M
- Minimum investment
- $7K
- Finders' fees
- $140.4K
- Placement agents
- Laidlaw & Company (UK) Ltd.
- First sale
- Apr 2022
- Incorporated
- Corporation, Nevada
- Federal exemptions
- 06b
▶$2.5MofferedMar 2021 · Other Health CareRule 506(b)
▶$2.5MofferedMar 2021 · Other Health Care
Rule 506(b)Officers, directors & promoters on the filing
- Joseph Michael RedmondExecutive Officer, Director
- Christine FarrellExecutive Officer
- John GandolfoDirector
- Jerome CaseyDirector
- Jeffrey ConroyDirector
- Jacob VanLandinghamDirector
- Offering amount
- $2.5M
- Minimum investment
- $25K
- Incorporated
- Corporation, Nevada
- Federal exemptions
- 06b
▶$1.1MraisedAug 2020 · 2 investors · Other Health CareRule 506(b)
▶$1.1MraisedAug 2020 · 2 investors · Other Health Care
Rule 506(b)Officers, directors & promoters on the filing
- John GandolfoDirector
- Christine FarrellExecutive Officer
- Jacob VanlandinghamDirector
- Jerome CaseyDirector
- Joseph Michael RedmondExecutive Officer, Director
- Jeffrey ConroyDirector
- Offering amount
- $11.1M
- Amount sold
- $1.1M
- Sales commissions
- $1.2M
- Proceeds to insiders
- $29K
- Placement agents
- A.G.P. / Alliance Global Partners
- First sale
- Aug 2020
- Incorporated
- Corporation, Nevada
- Federal exemptions
- 06b
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.
Valuation · disclosed
Disclosed events$57.4Mvaluation at IPOJul 2015 · $0.50/share · S-1/A
filing ↗Source: SEC prospectus filings, and round valuations the company or its investors disclosed — follow each entry's link for the claim.
Frequently asked questions
- What does Odyssey Group International do?
- Odyssey Health develops medical technologies aimed at addressing unmet clinical needs with significant market potential.
- How much funding has Odyssey Group International raised?
- Odyssey Group International has disclosed $2.6M raised across 2 of its 3 known rounds.
- Where is Odyssey Group International headquartered?
- Odyssey Group International is headquartered in Irvine, US.